Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Sensor Technologies (MST) is an innovative medical technology company that specializes in the development of advanced breath-analysis systems for non-invasive diagnostics. The company's flagship technology, the SpiroNose, utilizes a sophisticated array of electronic nose (eNose) sensors to detect specific patterns of Volatile Organic Compounds (VOCs) in exhaled breath, often referred to as a 'breathprint.' This platform is designed to provide real-time, point-of-care screening and monitoring for various respiratory conditions, including asthma, COPD, and lung cancer. By integrating sensor hardware with cloud-based artificial intelligence and machine learning algorithms, MST enables clinicians to differentiate between disease phenotypes and predict treatment responses. The company's solutions aim to reduce the need for invasive procedures while improving the speed and accuracy of diagnosis in both clinical and research settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Sensors Technologies.